Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Immunocore Holdings (NASDAQ:IMCR) over the past three months, with a majority being bullish. The average 12-month price target is $86.44, slightly down from the previous $87.11. Key analysts have maintained or lowered their ratings, reflecting varied sentiments about the company's future performance.
August 09, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Immunocore Holdings (NASDAQ:IMCR) received mixed ratings from analysts, with a majority being bullish. The average 12-month price target is $86.44, a slight decrease from the previous $87.11. Key analysts have maintained or lowered their ratings, indicating varied sentiments about the company's future performance.
The mixed ratings and slight decrease in the average price target suggest a neutral short-term impact on IMCR's stock price. While the majority of analysts are bullish, the slight decrease in the price target and some lowered ratings indicate caution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100